What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis.
作者信息
Frank Richard G
机构信息
The Brookings Institution, USA.
出版信息
Addiction. 2022 May;117(5):1198-1199. doi: 10.1111/add.15827.
PMID:35373489
Abstract
摘要
相似文献
1
What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis.
Addiction. 2022 May;117(5):1198-1199. doi: 10.1111/add.15827.
2
What lessons from France's experience could be applied in the United States in response to the addiction and overdose crisis?法国的经验中有哪些教训可以在美国应对成瘾和过量用药危机时加以应用？
Addiction. 2022 May;117(5):1191-1192. doi: 10.1111/add.15826.
3
What lessons from Norway's experience could be applied in the United States in response to the addiction and overdose crisis?挪威的经验中有哪些教训可以在美国应对成瘾和药物过量危机时加以应用？
Addiction. 2022 May;117(5):1192-1194. doi: 10.1111/add.15845.
4
What lessons from Sweden's experience could be applied in the United States in response to the addiction and overdose crisis?瑞典的经验中有哪些教训可以应用于美国，以应对成瘾和药物过量危机？
Addiction. 2022 May;117(5):1189-1191. doi: 10.1111/add.15847.
5
Class-wide REMS for extended-release and long-acting opioids: potential impact on pharmacies.广泛适用的缓释和长效阿片类药物的药品风险管理计划：对药房的潜在影响。
J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):e1-7. doi: 10.1331/JAPhA.2013.12025.
6
A crisis of opioids and the limits of prescription control: United States.阿片类药物危机和处方控制的局限性：美国。
Addiction. 2019 Jan;114(1):169-180. doi: 10.1111/add.14394. Epub 2018 Aug 27.
7
FDA Boxed Warning for Immediate-Release Opioids.美国食品药品监督管理局（FDA）对速释阿片类药物的黑框警告。
J Pain Palliat Care Pharmacother. 2016 Jun;30(2):141-5. doi: 10.3109/15360288.2016.1173762.
8
How FDA Failures Contributed to the Opioid Crisis.美国食品药品监督管理局的失误如何导致阿片类药物危机。
AMA J Ethics. 2020 Aug 1;22(1):E743-750. doi: 10.1001/amajethics.2020.743.
9
What lessons from Estonia's experience could be applied in the United States in response to the addiction and overdose crisis?爱沙尼亚的经验中有哪些教训可以在美国应对成瘾和药物过量危机时加以应用？
Addiction. 2022 May;117(5):1188-1189. doi: 10.1111/add.15833.
10
Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.阿片类药物风险管理的演变及对延长释放/长效阿片类药物的全类风险评估与管理计划的回顾。
Phys Sportsmed. 2012 Nov;40(4):12-20. doi: 10.3810/psm.2012.11.1975.
Zotero 插件